Patents by Inventor Alexander Knuth

Alexander Knuth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for detection of disease-associated antibodies in urine
    Publication number: 20020197659
    Abstract: The present invention provides methods and diagnostic kits for the detection of disease-specific antibodies in urine containing sample. The present invention is also directed toward methods for determining that a patient suffers from a disorder characterized by aberrant expression of a naturally occurring gene. Methods for monitoring the status of a disorder in a patient characterized by aberrant expression of a naturally occurring gene are also provided.
    Type: Application
    Filed: June 21, 2002
    Publication date: December 26, 2002
    Inventors: Alexander Knuth, Elke Jager, Dirk Jager
  • Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
    Patent number: 6448073
    Abstract: The invention relates to isolated, cancer associated antigens, nucleic acid molecules, and various uses thereof.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: September 10, 2002
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Dirk Jager, Elizabeth Stockert, Matthew Scanlan, Ali Gure, Elke Jager, Alexander Knuth, Lloyd Old, Yao-tseng Chen
  • SSX family proteins
    Patent number: 6339140
    Abstract: The invention relates to members of the SSX family of genes, as well as their uses.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: January 15, 2002
    Assignees: Ludwig Institute for Cancer Research, Cornell Medical Research Foundation, Memorial Sloan Kettering Cancer Center
    Inventors: Ali O. Gure, Ozlem Tureci, Ugur Sahin, Solam Tsang, Matthew J. Scanlan, Alexander Knuth, Michael Pfreundschuh, Lloyd J. Old, Yao-Tseng Chen
  • Isolated nucleic acid molecules encoding SSX family members and thereof
    Patent number: 6291658
    Abstract: The invention relates to members of the SSX family of genes, as well as their uses.
    Type: Grant
    Filed: May 5, 1997
    Date of Patent: September 18, 2001
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Ali O. Gure, Ozlem Tureci, Ugur Sahin, Solam Tsang, Matthew J. Scanlan, Alexander Knuth, Michael Pfreundschuh, Lloyd J. Old, Yao-Tseng Chen
  • Method for determining status of a cancerous condition by determining antibodies to NY-ESO-1 in a patient sample
    Patent number: 6251603
    Abstract: The invention relates to methods for determining tumor status by determining antibodies specific to NY-ESO-1 in patient samples. One can determine whether a cancerous condition is progressing, regressing, or remaining stable by determining antibodies against NY-ESO-1 in a patient sample, and comparing the value obtained to a prior value. When the tumor in question expresses NY-ESO-1, a change in this value is indicative of a change in status of the cancerous condition.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: June 26, 2001
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Elke Jäger, Elisabeth Stockert, Lloyd J. Old, Alexander Knuth
  • Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
    Patent number: 6096313
    Abstract: Granulocyte-macrophage colony stimulating factor ("GM-CSF") has been found to act as an adjuvant when administered to subjects. Compositions of GM-CSF and immunogenic compositions are presented, as is the use of GM-CSF alone and in these compositions.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: August 1, 2000
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Elke Jager, Alexander Knuth